{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:50:48Z","timestamp":1791827448205,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Diabetes Metab Disord"],"DOI":"10.1007\/s40200-026-02107-y","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:26:02Z","timestamp":1791825962000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The hepato-thyroid axis in male obesity: unraveling inter-organ crosstalk through non-invasive biomarkers"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7181-2944","authenticated-orcid":false,"given":"Mohammadjavad","family":"Sotoudeheian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Pirhayati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Azarbad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Sedigh","family":"Dakkali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir M.","family":"Sadeghian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed-Mohamad-Sadegh","family":"Mirahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"key":"2107_CR1","doi-asserted-by":"crossref","unstructured":"Chen S, Jin Y, Xu M, et al. Relationship between thyroid hormone and liver steatosis analysis parameter in obese participants: a case-control study. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2022:887\u2013896.","DOI":"10.2147\/DMSO.S356882"},{"key":"2107_CR2","doi-asserted-by":"crossref","unstructured":"Borges-Canha M, Neves JS, Mendonca F, et al. Thyroid function and the risk of non-alcoholic fatty liver disease in morbid obesity. Frontiers in endocrinology. 2020;11:572128.","DOI":"10.3389\/fendo.2020.572128"},{"key":"2107_CR3","doi-asserted-by":"crossref","unstructured":"Pacifico L, Bonci E, Ferraro F, Andreoli G, Bascetta S, Chiesa C. Hepatic steatosis and thyroid function tests in overweight and obese children. International journal of endocrinology. 2013;2013:381014.","DOI":"10.1155\/2013\/381014"},{"key":"2107_CR4","doi-asserted-by":"crossref","unstructured":"Bano A, Chaker L, Muka T, et al. Thyroid function and the risk of fibrosis of the liver, heart, and lung in humans: a systematic review and meta-analysis. Thyroid. 2020;30:806\u2013820.","DOI":"10.1089\/thy.2019.0572"},{"key":"2107_CR5","doi-asserted-by":"publisher","DOI":"10.1155\/ije\/9291433","volume":"2026","author":"W Huang","year":"2026","unstructured":"Huang W, Yao J, Shi Y, Huang H. Association between thyroid function indicators and metabolic-associated fatty liver disease: effect modification by iodine nutritional status. Int J Endocrinol. 2026;2026:9291433.","journal-title":"Int J Endocrinol"},{"key":"2107_CR6","doi-asserted-by":"crossref","unstructured":"Ding Q, Li K, Lin S, Qiu R, Wu G. The association between the weight-adjusted waist circumference index (WWI) and thyroid function: an NHANES study. Hormones. 2026:1\u201310.","DOI":"10.1007\/s42000-026-00781-4"},{"key":"2107_CR7","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1161\/CIRCRESAHA.124.325535","volume":"136","author":"H Ayesh","year":"2025","unstructured":"Ayesh H, Nasser SA, Ferdinand KC, Carranza Leon BG. Sex-specific factors influencing obesity in women: bridging the gap between science and clinical practice. Circ Res. 2025;136:594\u2013605.","journal-title":"Circ Res"},{"key":"2107_CR8","doi-asserted-by":"crossref","unstructured":"Lovejoy JC. The influence of sex hormones on obesity across the female life span. Journal of Women\u2019s Health. 1998;7:1247\u20131256.","DOI":"10.1089\/jwh.1998.7.1247"},{"key":"2107_CR9","doi-asserted-by":"crossref","unstructured":"Jain R. Thyroid profile of the reference United States population: Data from NHANES 2007\u20132012. Int Arch Endocrinol Clin Res. 2015;1.","DOI":"10.23937\/2572-407X.1510004"},{"key":"2107_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8894792","author":"A Baranowska-Bik","year":"2020","unstructured":"Baranowska-Bik A, Bik W. The association of obesity with autoimmune thyroiditis and thyroid function-possible mechanisms of bilateral interaction. Int J Endocrinol. 2020. https:\/\/doi.org\/10.1155\/2020\/8894792.","journal-title":"Int J Endocrinol"},{"key":"2107_CR11","doi-asserted-by":"crossref","unstructured":"Zhang X, Chen Y, Ye H, et al. Correlation between thyroid function, sensitivity to thyroid hormones and metabolic dysfunction-associated fatty liver disease in euthyroid subjects with newly diagnosed type 2 diabetes. Endocrine. 2023;80:366\u2013379.","DOI":"10.1007\/s12020-022-03279-2"},{"key":"2107_CR12","doi-asserted-by":"crossref","unstructured":"Coppola M, Glinni D, Moreno M, Cioffi F, Silvestri E, Goglia F. Thyroid hormone analogues and derivatives: actions in fatty liver. World journal of hepatology. 2014;6:114.","DOI":"10.4254\/wjh.v6.i3.114"},{"key":"2107_CR13","doi-asserted-by":"publisher","first-page":"645","DOI":"10.4103\/ijem.IJEM_25_18","volume":"22","author":"P Punekar","year":"2018","unstructured":"Punekar P, Sharma AK, Jain A. A study of thyroid dysfunction in cirrhosis of liver and correlation with severity of liver disease. Indian J Endocrinol Metab. 2018;22:645\u201350.","journal-title":"Indian J Endocrinol Metab"},{"key":"2107_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/goad076","volume":"12","author":"Z Li","year":"2024","unstructured":"Li Z, Wu X, Chen Z, Wei X, Chen W. Association between low-normal thyroid function and advanced liver fibrosis in metabolic dysfunction-associated fatty liver disease patients: a retrospective cohort study. Gastroenterol Rep. 2024;12:goad076.","journal-title":"Gastroenterol Rep"},{"key":"2107_CR15","doi-asserted-by":"crossref","unstructured":"Zhang X, Zhang J, Dai Y, Qin J. Serum thyroid hormones levels are significantly associated with nonalcoholic fatty liver disease in euthyroid chinese population. Clinical Laboratory. 2020.","DOI":"10.7754\/Clin.Lab.2020.200219"},{"key":"2107_CR16","doi-asserted-by":"crossref","unstructured":"Ma D, Zeng J, Huang B, et al. Independent associations of thyroid-related hormones with hepatic steatosis and insulin resistance in euthyroid overweight\/obese Chinese adults. BMC gastroenterology. 2021;21:431.","DOI":"10.1186\/s12876-021-02011-0"},{"key":"2107_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-32245-0","volume":"8","author":"J Lee","year":"2013","unstructured":"Lee J, Ha J, Jo K, et al. Male-specific association between subclinical hypothyroidism and the risk of non-alcoholic fatty liver disease estimated by hepatic steatosis index: Korea National Health and Nutrition Examination Survey 2013 to 2015. Sci Rep. 2013;8:15145.","journal-title":"Sci Rep"},{"key":"2107_CR18","unstructured":"Layegh P, Asadi A, Jangjoo A, et al. Comparison of thyroid volume, TSH, free t4 and the prevalence of thyroid nodules in obese and non-obese subjects and correlation of these parameters with insulin resistance status. Caspian journal of internal medicine 2020;11:278."},{"key":"2107_CR19","doi-asserted-by":"crossref","unstructured":"He J, Lai Y, Yang J, et al. The relationship between thyroid function and metabolic syndrome and its components: a cross-sectional study in a Chinese population. Frontiers in endocrinology. 2021;12:661160.","DOI":"10.3389\/fendo.2021.661160"},{"key":"2107_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/liv.15723","volume":"44","author":"N Saatmann","year":"2024","unstructured":"Saatmann N, Sch\u00f6n M, Zaharia OP, et al. Association of thyroid function with non-alcoholic fatty liver disease in recent\u2010onset diabetes. Liver Int. 2024;44:27\u201338.","journal-title":"Liver Int"},{"key":"2107_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-022-02612-3","volume":"23","author":"H Fan","year":"2023","unstructured":"Fan H, Li L, Liu Z, et al. Low thyroid function is associated with an increased risk of advanced fibrosis in patients with metabolic dysfunction-associated fatty liver disease. BMC Gastroenterol. 2023;23:3.","journal-title":"BMC Gastroenterol"},{"key":"2107_CR22","doi-asserted-by":"publisher","DOI":"10.2147\/dmso.s420872","author":"H Liu","year":"2023","unstructured":"Liu H, Xing Y, Nie Q, Li Z, Meng C, Ma H. Association between sensitivity to thyroid hormones and metabolic dysfunction-associated fatty liver disease in euthyroid subjects: a cross-sectional study. Diabetes Metab Syndr Obes. 2023. https:\/\/doi.org\/10.2147\/dmso.s420872.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2107_CR23","doi-asserted-by":"crossref","unstructured":"He W, Huang C, Wang L, et al. The correlation between triiodothyronine and the severity of liver fibrosis. BMC Endocrine Disorders. 2022;22:313.","DOI":"10.1186\/s12902-022-01228-8"},{"key":"2107_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13070","volume":"49","author":"P Chen","year":"2019","unstructured":"Chen P, Hou X, Wei L, et al. Free triiodothyronine is associated with the occurrence and remission of nonalcoholic fatty liver disease in euthyroid women. Eur J Clin Invest. 2019;49:e13070.","journal-title":"Eur J Clin Invest"},{"key":"2107_CR25","doi-asserted-by":"crossref","unstructured":"Tacke F, Horn P, Wong VW-S, et al. EASL\u2013EASD\u2013EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). Journal of hepatology. 2024;81:492\u2013542.","DOI":"10.1016\/j.jhep.2024.04.031"},{"key":"2107_CR26","doi-asserted-by":"publisher","DOI":"10.2174\/0127724328328193241029103831","author":"MJ Sotoudeheian","year":"2024","unstructured":"Sotoudeheian MJ, Azarbad R, Mirahmadi S-M-S, Farahmandian N. The role of metformin in modifying ferroptosis to treat metabolic dysfunction-associated fatty liver disease: a narrative review. Curr Rev Clin Exp Pharmacol. 2024. https:\/\/doi.org\/10.2174\/0127724328328193241029103831.","journal-title":"Curr Rev Clin Exp Pharmacol"},{"key":"2107_CR27","doi-asserted-by":"crossref","unstructured":"Khanna D, Khanna S, Khanna P, Kahar P, Patel BM. Obesity: a chronic low-grade inflammation and its markers. Cureus. 2022;14.","DOI":"10.7759\/cureus.22711"},{"key":"2107_CR28","doi-asserted-by":"publisher","first-page":"6184","DOI":"10.3390\/ijms15046184","volume":"15","author":"UJ Jung","year":"2014","unstructured":"Jung UJ, Choi M-S. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci. 2014;15:6184\u2013223.","journal-title":"Int J Mol Sci"},{"key":"2107_CR29","doi-asserted-by":"crossref","unstructured":"Marschner RA, Arenhardt F, Ribeiro RT, Wajner SM. Influence of altered thyroid hormone mechanisms in the progression of metabolic dysfunction associated with fatty liver disease (MAFLD): a systematic review. Metabolites. 2022;12:675.","DOI":"10.3390\/metabo12080675"},{"key":"2107_CR30","doi-asserted-by":"crossref","unstructured":"Cheng H, Hu Y, Zhao H, et al. Exploring the association between triglyceride-glucose index and thyroid function. European Journal of Medical Research. 2023;28:508.","DOI":"10.1186\/s40001-023-01501-z"},{"key":"2107_CR31","doi-asserted-by":"publisher","DOI":"10.15584\/ejcem.2022.4.5","author":"C Onur Kirac","year":"2022","unstructured":"Onur Kirac C, Sirikci V, Avni Findikli H. Comparison of triglyceride-glucose index and HOMA-IR as indicators of insulin resistance in obese women with subclinical hypothyroidism. Eur J Clin Exp Med. 2022. https:\/\/doi.org\/10.15584\/ejcem.2022.4.5.","journal-title":"Eur J Clin Exp Med"},{"key":"2107_CR32","doi-asserted-by":"crossref","unstructured":"Tutunchi H, Naeini F, Mobasseri M, Ostadrahimi A. Triglyceride glucose (TyG) index and the progression of liver fibrosis: A cross-sectional study. Clinical Nutrition ESPEN. 2021;44:483\u2013487.","DOI":"10.1016\/j.clnesp.2021.04.025"}],"container-title":["Journal of Diabetes &amp; Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40200-026-02107-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40200-026-02107-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40200-026-02107-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:26:06Z","timestamp":1791825966000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40200-026-02107-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":32,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2107"],"URL":"https:\/\/doi.org\/10.1007\/s40200-026-02107-y","relation":{},"ISSN":["2251-6581"],"issn-type":[{"value":"2251-6581","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,12]]},"assertion":[{"value":"3 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The studies involving human participants were reviewed and approved by Centers for Disease Control and Prevention (Protocol #2011-17) in accordance with the Declaration of Helsinki. The participants provided their written informed consent to participate in this study.","order":1,"name":"Ethics","label":"<b>Ethical approval<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided their written informed consent to participate in NHANES survey.","order":2,"name":"Ethics","label":"Human ethics and Consent to participate declarations","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided their written informed consent to participate in NHANES survey.","order":3,"name":"Ethics","label":"<b>Consent to participate<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"288"}}